Clinical trial
Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin
NCT00287664 · Hospital Clinic of Barcelona, Other · Suspended
Key facts
| NCT number | NCT00287664 |
|---|---|
| Title | Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin |
| Official title | Terlipressin as Treatment of Patients With Cirrhosis and Hepatorenal Syndrome. Effect on Survival and Renal Function. Multicenter, Randomized and Prospective Study |
| Lead sponsor | Hospital Clinic of Barcelona, Other |
| Collaborators | Grant from Education Ministery from 2001-2004. |
| Status | Suspended |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cirrhosis, Hepatorenal Syndrome |
| Intervention type | Drug |
| Interventions | terlipressin |
| Enrollment | 100 |
| Start date | Feb 1, 2002 |
| Completion | Sep 1, 2006 |
| First posted | Feb 7, 2006 |
| Last update posted | Apr 11, 2007 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: